Science Advisory Board | Instant News

Science Advisory Board<br />

COVID-19 has long-term effects on the biotechnology industry

January 5, 2021 – The COVID-19 pandemic will have far-reaching and lasting effects on the biotechnology industry, according to speakers at a January 5 presentation held ahead of the virtual Biotech Showcase being held on January 11-15. Biotech companies have been swirling around on a large scale pursuing infectious disease research – and not all of them will succeed.

An allergic reaction to the COVID-19 vaccine should not stop vaccination

January 4, 2021 – The COVID-19 vaccine currently approved for emergency use by the US Food and Drug Administration (FDA) is safe even among people with food or drug allergies, according to allergists from Massachusetts General Hospital. A review of all relevant information is published on Journal of Allergy and Clinical Immunology: In Practice on December 31st.

Top 10 ScienceBoard stories for 2020

21 December 2020 – For many of us, 2020 didn’t go according to plan. The emergence of the COVID-19 pandemic has drastically changed our daily lives. Right here at, we have provided our readers with timely and evidence-based information regarding COVID-19, as well as many other topics in the biopharmaceutical and life sciences industry.

The FDA issued the EUA for the Moderna COVID-19 vaccine

18 December 2020 – Just one day after the committee’s favorable recommendation, the US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the COVID-19 messenger RNA (mRNA) vaccine from Moderna. The company’s mRNA-1273 vaccine is now the second COVID-19 vaccine on the US market, after vaccines from Pfizer and BioNTech were administered EUA last week.

New discoveries could produce broad-spectrum antivirals

18 December 2020 – Scientists have identified key human genes that cells need to consume and destroy viruses. Research results are published in Natural on December 16 and could demonstrate new treatments to target viral infections, including COVID-19.

The FDA committee voted in favor of the Moderna COVID-19 EUA vaccine

17 December 2020 – Moderna’s COVID-19 messenger RNA (mRNA) vaccine candidate, mRNA-1273, received favorable recommendations on December 17 from an advisory committee for the US Food and Drug Administration (FDA). The OK Committee means that mRNA-1273 may receive emergency use authorization (EUA) within a few days.

The new immunotherapy supports the polio vaccine to treat cancer

17 December 2020 – As if we needed another reason to get vaccinated, researchers have developed technology that uses the polio vaccine to help treat cancer in those who later develop the disease. The technology, developed at Duke University and developed by Istari Oncology, uses the antigen produced by the polio vaccine to trigger the immune system to eat away at targeted cancer cells.

The genes provide new targets for COVID-19 therapy

15 December 2020 – Genes associated with antiviral immunity and lung inflammation have been linked to severe cases of COVID-19 in a new genome analysis carried out in the UK. The result, published in Natural on December 11, revealed new therapeutic targets for drug reuse and development efforts.

Global health R&D has stalled as resources shifted to COVID-19

December 14, 2020 – The current coronavirus pandemic has slowed progress in research and development (R&D) on neglected diseases and other long-term global health challenges by disrupting ongoing research and directing resources to the work of COVID-19, according to a new report released on December 11. by the nonprofit Global Health Technologies Coalition.

The FDA issued the EUA for Pfizer’s vaccine, BioNTech COVID-19

12 December 2020 – The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. This step comes after the FDA’s Vaccines and Biological Products Advisory Committee issued positive recommendations for the vaccine.

Google’s DeepMind is making a quantum leap in solving the problem of protein folding

11 December 2020 – Artificial intelligence has made breakthroughs in protein structure prediction. The results come as part of the 14th Critical Assessment of Structure Prediction, a friendly contest and conference organized by the Protein Structure Prediction Center with sponsorship from the National Institute of General Medical Sciences, part of the US National Institutes of Health.


image source

to request modification Contact us at Here or [email protected]